Collaborative Robots and the Future of Research and Development in Biotechnology (Nanobiotechnology)
Overview
The future of research and development in the field of Biotechnology and specifically Nanobiotechnology is evolving rapidly as a result of the incorporation of collaborative robots, or "cobots." These cobots, combined with machine learning and artificial intelligence, are poised to transform numerous processes, increasing efficiency and productivity. Key statistics pointing towards this include an expected CAGR increase of 44.5% from 2020-2025, the projection of the cobots market to reach $15 billion by 2023, and the triumph of reduced labor costs by 22% in this realm.
Advancement in Nanobiotechnology with Cobots
With advancements in robot-human interaction technology, the integration of collaborative robots in research and development is escalating. In Nanobiotechnology, this utilization leads to remarkable efficiency. According to the International Federation of Robotics, the cobots market is projected to see a CAGR increase of 44.5% from 2020 to 2025. Cobots' application in laboratory processes, such as drug discovery and nanoparticle characterization, is set to enhance precision, speed and repeatability.
Investment in Cobots for Research and Development
Investment in cobots for research purposes is soaring due to the manifold benefits they offer. Leading market research firms anticipate the collaborative robotics market to reach around $15 billion by 2023, a significant surge from $710 million in 2018. These significant investments indicate a high level of faith in cobots' transformative potential in the field of Biotechnology.
Economic Efficiency with Cobots
Cobots have been proven to drastically reduce labor costs. According to a study in Industrial Robotics, companies that integrate cobots in their operations can expect to see labor costs drop by 22% by 2025. A prime example is their use in drug discovery processes in Nanobiotechnology where reductions in time and error rates are considerable.
Key Takeaways
- The cobots market is expected to increase by 44.5% from 2020 to 2025.
- Investment in cobots is predicted to surge, with the market reaching $15 billion by 2023.
- Cobots can result in a 22% reduction in labor costs by 2025.
How 3Laws Robotics can support the above use cases
3Laws Robotics is addressing the future needs of research and development in Biotechnology and Nanobiotechnology. This company is developing innovative software, 3Laws Supervisor, aimed at enhancing safety and reliability of robotic systems while simplifying the challenging certification process, a notable pain point for many robotics companies.
Among the diverse industry and application use cases, 3Laws has facilitated a 40% efficiency gain in warehouse automation, enabling safe and uninterrupted operation of robots in human-robot interaction scenarios, and capitalized on its reactive collision avoidance capabilities to help robots thrive in dynamic environments.
3Laws’ state-of-the-art software is built on Control Barrier Functions, a technology developed at Caltech. By minimizing downtime caused by unnecessary e-stops or collisions and providing real-time guardrails for robotic systems, 3Laws allows robots to operate at their peak capabilities without compromising safety.
Compatible with popular robotics middleware such as ROS and ROS2, it positions 3Laws as a next-generation safety solution that transcends traditional e-stop methods. Its dynamic, predictive safety approach, certifiable for ISO 3691-4 and ISO 26262, embodies the full potential of robotics, unlocking vast possibilities for the future of research and development in Nanobiotechnology.